| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 03/02/2004 | US6699671 Polypeptide sequence encoding beta secretase enzyme, termed aspartyl protease 2 (as p2) involved in processing amyloid precursor protein (app) into amyloid beta; drug screening for the enzyme inhibitor |
| 03/02/2004 | US6699654 Antimicrobial agents diagnostic reagents, and vaccines based on unique apicomplexan parasite components |
| 03/02/2004 | US6699515 Process for the production of alcoholic beverages using maltseed |
| 03/02/2004 | CA2229405C Methods for enhancing the production of interferon in cell culture |
| 02/26/2004 | WO2004017044A2 Chimeric protein |
| 02/26/2004 | WO2004016814A1 Method of estimating drug metabolic activity by analyzing mutations in glucuronosyl transferase gene |
| 02/26/2004 | WO2004016795A1 Methods for inducing targeted stimulation of meiotic recombination and kits for performing said methods |
| 02/26/2004 | WO2004016790A1 Novel n-acetylgalactosamine transferases and nucleic acids encoding the same |
| 02/26/2004 | WO2004016773A1 Transgenic cloned cow producing human prourokinase and method for producing the same |
| 02/26/2004 | WO2004016764A2 eNOS MUTANTS USEFUL FOR GENE THERAPY |
| 02/26/2004 | WO2004016761A2 Gene therapy for critical limb ischemia with wild type or mutant enos |
| 02/26/2004 | WO2004016760A2 Novel variant hyprocrea jecorina cbh1 cellulases |
| 02/26/2004 | WO2004016756A2 Promoter motifs in candida tropicalis |
| 02/26/2004 | WO2004016752A2 Proteome-wide mapping of post-translational modifications using endonucleases |
| 02/26/2004 | WO2004016742A2 α(1,3)-GALACTOSYLTRANSFERASE NULL CELLS, METHODS OF SELECTING AND α(1,3)-GALACTOSYLTRANSFERASE NULL SWINE PRODUCED THEREFROM |
| 02/26/2004 | WO2004016730A2 Bacteria that can overproduce and secrete proteins |
| 02/26/2004 | WO2004016646A2 Peptide modulators of tumour specific pyruvate kinase subtype m2 (m2-pk) |
| 02/26/2004 | WO2004016223A2 Assaying compounds or agents for microsomal prostaglandin e synthase or hematopoietic prostaglandin d synthase activity |
| 02/26/2004 | WO2004016220A2 Apicomplexan pathways, inhibitiors, and drug delivery |
| 02/26/2004 | WO2004016212A2 Methods and compositions for targeting secretory lysosomes |
| 02/26/2004 | WO2004016073A2 Wheat plants having increased resistance to imidazolinone herbicides |
| 02/26/2004 | WO2004003188A3 Stabilization of granules |
| 02/26/2004 | WO2003089618A3 Transposon system and methods of use |
| 02/26/2004 | WO2003089599A3 Ligand sensing fluorescent acetylcholinesterase for detection of organophosphate activity |
| 02/26/2004 | WO2003083050A3 Human deubiquitinating protease gene on chromosome 7 and its murine ortholog |
| 02/26/2004 | WO2003068926A3 Over-expression of extremozyme genes in pseudomonads and closely related bacteria |
| 02/26/2004 | WO2003068911A3 Citrus tristeza virus resistance genes and methods of use |
| 02/26/2004 | WO2003066815A3 Method for producing 2-hydroxyisobutyric acid and methacrylic acid from acetone cyanohydrin |
| 02/26/2004 | WO2003062409A3 Thermostable enzyme compositions |
| 02/26/2004 | WO2003061583A3 Digenic mutations associated with severe insulin resistance and type 2 diabetes and their use in the diagnosis and treatment of diabetes |
| 02/26/2004 | WO2003060152A3 Alteration of restriction endonuclease specificity by genetic selection |
| 02/26/2004 | WO2003055975A3 A method for engineering strand-specific, sequence-specific, dna-nicking enzymes |
| 02/26/2004 | WO2003054147A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/26/2004 | WO2003049547A3 Dairy process and product |
| 02/26/2004 | WO2003040325A3 Novel proteins and nucleic acids encoding same |
| 02/26/2004 | WO2003039474A3 Method and composition for the modulation of angiogenesis |
| 02/26/2004 | WO2003035840A3 69583 and 85924, novel human protein kinase family members and uses therefor |
| 02/26/2004 | WO2003034812A3 Aromatic methyltransferases and uses thereof |
| 02/26/2004 | WO2003006641A9 Epsti1, a gene induced by epithelial-stromal interaction in human breast cancer |
| 02/26/2004 | WO2003002711A3 A NOVEL GROUP OF α-AMYLASES AND A METHOD FOR IDENTIFICATION AND PRODUCTION OF NOVEL α-AMYLASES |
| 02/26/2004 | WO2002103002A3 Gene associated with leishmania parasite virulence |
| 02/26/2004 | WO2002101003A3 Stereoselective preparation of cyclic l-amino acids |
| 02/26/2004 | WO2002083869A3 Product and process for transformation of thraustochytriales microorganisms |
| 02/26/2004 | WO2002066672A3 Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists |
| 02/26/2004 | WO2002046382A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/26/2004 | WO2002045499A3 Transgenic mice containing deubiquitinated enzyme gene disruptions |
| 02/26/2004 | WO2002042424A3 Seed-preferred regulatory elements and uses thereof |
| 02/26/2004 | WO2002040656A3 47476, 67210, 49875, 46842, 33201, 83378, 84233, 64708, 85041, and 84234, novel human guanine nucleotide dissociation stimulator, glycosyltransferase, dead type helicase, centaurin, dehydrogenase/reductase, and metal transporter family members and uses thereof |
| 02/26/2004 | WO2002040542A3 58569 and 50111, human anion exchange proteins and methods of use thereof |
| 02/26/2004 | WO2002038775A3 METHODS FOR PRODUCING AND PURIFYING RECOMBINANT α-L-IDURONIDASE |
| 02/26/2004 | WO2002036757A3 Enzymes involved in glycoprotein and glycolipid metabolism |
| 02/26/2004 | WO2001074299A3 Compositions and methods for inhibition of cancer invasion and angiogenesis |
| 02/26/2004 | WO2001057175A3 Methods and materials relating to neurotrimin-like polypeptides and polynucleotides |
| 02/26/2004 | US20040040048 Introducing atransgene into an embryo of the animal, which containing a nucleic acid encoding phytase, transplanting the embroy into a pseudopregnanat animal, allowing embryo to develop to term, detecting offspring expressing the transgene |
| 02/26/2004 | US20040039186 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 02/26/2004 | US20040039164 Invention relates to identification and isolation of novel DNA and to recombinant production of novel polypeptides |
| 02/26/2004 | US20040039046 Scyphostatin analogues as SMase inhibitors |
| 02/26/2004 | US20040038896 For diagnosis and therapy |
| 02/26/2004 | US20040038893 Prevention and reduction of blood loss |
| 02/26/2004 | US20040038881 For diagnosis, therapy and prophylaxis of cancer, immune disorders, disorders affecting growth and development, cardiovascular diseases, and lipid disorders |
| 02/26/2004 | US20040038841 For use in detergents, treating paper pulp, deinking waste paper |
| 02/26/2004 | US20040038417 Method for identifying and/or characterizing a (poly)peptide |
| 02/26/2004 | US20040038407 From plants having decreased content of anthocyanins; enzyme inhibitors |
| 02/26/2004 | US20040038382 Comprises genes encoding toluene-degrading enzymes having homology to Escherichia coli pyruvate formate lyase; waste treatment; pollution control |
| 02/26/2004 | US20040038381 Comprises genetically engineered strains of Pichia; mannosidases; glycoproteins; kits |
| 02/26/2004 | US20040038377 Diagnostic test for Alzheimer's disease |
| 02/26/2004 | US20040038375 Method for screening highly active proteases and inhibitors |
| 02/26/2004 | US20040038372 Process for the production of amino acids with coryneform bacteria using phosphoglucose isomerases from coryneform bacteria |
| 02/26/2004 | US20040038371 Aminopeptidase |
| 02/26/2004 | US20040038369 Airway-specific trypsin-like enzymes and method of using the same |
| 02/26/2004 | US20040038368 Improved pH stability; for washing and/or dishwashing detergents |
| 02/26/2004 | US20040038367 Which cleaves the second beta-glucoside linkage of xyloglucans; isolated from Geotrichum species |
| 02/26/2004 | US20040038366 Improved heat resistance; genetic engineering |
| 02/26/2004 | US20040038365 Fusion proteins; for treatment/prevention of cancer, central nervous system disorders, obesity, chronic obstructive pulmonary disease, diabetes, and cardiovascular disorders; drug screening; kits |
| 02/26/2004 | US20040038364 Such as snake venom proteases; anticoagulants |
| 02/26/2004 | US20040038363 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/26/2004 | US20040038362 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/26/2004 | US20040038361 Novel protein kinase (NPK-110) |
| 02/26/2004 | US20040038360 Ethanolaminephosphate cytidylyltransferase gene and promoter |
| 02/26/2004 | US20040038358 Contains a ubiquitin pathway protein binding moiety which recognizes a ubiquitin pathway protein and a targeting moiety which recognizes a target protein |
| 02/26/2004 | US20040038357 Producing a fagopyritol, an insulin mediator, an insulin mediator analogue, an insulin mediator homologue, or an insulin mediator inhibitor |
| 02/26/2004 | US20040038351 By reacting glyceraldehyde 3-phosphate and acetaldehyde in the presence of either a microorganism itself which contains 2-deoxyribose-5- phosphate aldolase but substantially no phosphatase or the enzyme derived from the microorganism |
| 02/26/2004 | US20040038346 Vectors, host cells, and recombinant methods for making and using the novel molecules |
| 02/26/2004 | US20040038340 Used in the processing of fermented foods by imparting an improved texture and flavor, and/or a higher content in aroma compounds; mutant has a mutation impairing the regulation of a carbon catabolite repression (CCR) mechanism |
| 02/26/2004 | US20040038337 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/26/2004 | US20040038336 Identification and isolation of novel DNA and to the recombinant production of novel polypeptides |
| 02/26/2004 | US20040038335 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/26/2004 | US20040038334 Thermal tolerant avicelase from acidothermus cellulolyticus |
| 02/26/2004 | US20040038333 Methods for protein refolding |
| 02/26/2004 | US20040038330 Inhibitor of hepatitis B and HIV activity |
| 02/26/2004 | US20040038317 Identifying functional fragment pairs/activation/binding sites in protein for screening and monitoring therapeutic and imaging reagents in vivo; for detection and treatment of cancer, inflammation, atherosclerosis and infection |
| 02/26/2004 | US20040038297 Masp-2,a complement-fixing enzyme, and uses for it |
| 02/26/2004 | US20040038290 Comprises nucleotide sequences coding heat resistant polymerase for use as DNA replication/amplification tool in genetic engineering |
| 02/26/2004 | US20040038289 Nucleic acid encoding bacillus stearothermophilus delta polymerase subunit |
| 02/26/2004 | US20040038288 Human protein C Polypeptide |
| 02/26/2004 | US20040038287 Nucleic acid encoding a wheat brittle-1 homolog |
| 02/26/2004 | US20040038286 Comprises nucleotide sequences coding oxalyl-CoA decarboxylase for diagnosis and treatment of kidney, lipid malabsorptive and inflammatory bowel diseases |
| 02/26/2004 | US20040038285 Comprises polypeptide which possess hematopoietic, tissue generative/regeneration, activin/inhibin, chemotactic, hemostatic and thrombolytic activity for prevention and treatment autoimmune, viral and tumor disorders |
| 02/26/2004 | US20040038262 Ribulose 1,5-bisphosphate carboxylase/oxygenase polypeptides and related polynucleotides |
| 02/26/2004 | US20040038257 Therapeutic peptidase for diagnosis, treatment and prevention of cancer and nervous system disorders |